Combined effects of soy isoflavone and lecithin on bone loss in ovariectomized mice

• Published in: Nutrition research and practice Vol. 15; no. 5; pp. 541 - 554
• Main Authors: Kim, Sang Baek, Assefa, Freshet, Lee, Su Jeong, Park, Eui Kyun, Kim, Sung Soo
• Format: Journal Article
• Language: English
• Published: 한국영양학회 01.10.2021; The Korean Nutrition Society and the Korean Society of Community Nutrition
• Subjects: Original Research; 생활과학; lecithin; bone; bone density; Isoflavones
• ISSN: 1976-1457; 2005-6168
• DOI: 10.4162/nrp.2021.15.5.541

BACKGROUND/OBJECTIVESIsoflavones (ISFs) are effective in preventing bone loss, but not effective enough to prevent osteoporosis. Mixtures of soy ISF and lecithin (LCT) were prepared and characterized in an attempt to improve the bone loss. MATERIALS/METHODSThe daidzein (DZ) and genistein (GN) solubility in soy ISF were measured using liquid chromatography-mass spectrometry. The change in the crystalline characteristics of soy ISF in LCT was evaluated using X-ray diffraction analysis. Pharmacokinetic studies were conducted to evaluate and compare ISF bioavailability. Animal studies with ovariectomized (OVX) mice were carried out to estimate the effects on bone loss. The Student's t-test was used to evaluate statistical significance. RESULTSThe solubility of DZ and GN in LCT was 125.6 and 9.7 mg/L, respectively, which were approximately 25 and 7 times higher, respectively, than those in water. The bioavailability determined by the area under the curve of DZ for the oral administration (400 mg/kg) of soy ISF alone and the soy ISF-LCT mixture was 13.19 and 16.09 µg·h/mL, respectively. The bone mineral density of OVX mice given soy ISF-LCT mixtures at ISF doses of 60 and 100 mg/kg daily was 0.189 ± 0.020 and 0.194 ± 0.010 g/mm3, respectively, whereas that of mice given 100 mg/kg soy ISF was 0.172 ± 0.028 g/mm3. The number of osteoclasts per bone perimeter was reduced by the simultaneous administration of soy ISF and LCT. CONCLUSIONSThe effect of preventing bone loss and osteoclast formation by ingesting soy ISF and LCT at the same time was superior to soy ISF alone as the bioavailability of ISF may have been improved by the emulsification and solvation of LCT. These results suggest the possibility of using the combination of soy ISF and LCT to prevent osteoporosis.